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Abstract: The paper presents a theoretical synthesis and scientific
solution of scientific problem, grounded on the experimental side
effects of broad-spectrum antibiotic (tetracycline hydrochloride) on
qualitative and quantitative composition of the microbiota in the
biological layer on mucus membrane of colon and distal part of small
intestine;substantiation of self-healing process within 10 days
qualitative and quantitative composition of the microbiota of given
biotype, depending on the dose of tetracycline (average and
maximum therapeutic dose) orally administered white rats, and the
influence of probiotic "Child powder Bifiform number 21" on the
restoration of the qualitative and quantitative composition of the gut
microbiome.
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Accumulated in our country and around the world
a vast experience of antibiotics allowed review of
the basic principles and concept of their purpose, to
make the most efficient use of different groups of
antibiotics, however, to prevent or minimize the level
of side effects and complications of varying severity.
Determination of the optimal dose of antibiotic in the
causal treatment is extraordinary and crucial to the
successful treatment of bacterial infectious diseases
[1, 2]. The inefficiency of causal antibiotic therapy
may be associated with uneffective selection of
therapeutic doses. Small doses often provide
therapeutic concentrations in the blood and tissues,
but leading to a lack of success in treatment, or
transition of diseases to a chronic form, and the
formation of resistance of the pathogen to antibiotic
[3]. A typical example of this error is the usage of
tetracyclines in adult patients of a single dose of 10
mg / kg or less,while the average therapeutic dose is
20 mg / kg [4].
The use of antibiotics in medical practice, in some
cases is accompanied by the development of side
effects, reactions, life-threatening to patients. In
recent years, this problem is given the utmost
importance both in domestic and foreign publications.
Years of experience in the use of antibiotics leads to
the objective analysis and synthesis of their
application and to the formulationof basic
fundamental concepts of characteristics of adverse
reactions and processes [5]. In most cases, causal
treatment with antibiotics is accompanied by the
formation of varying degrees of intestinal dysbiosis /
dysbacteriosis. Formed under the influence of
various factors, primarily on the use of antibiotics,
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gastro - intestinal dysbiosiscan be hardly corrected,
which significantly complicates the course of disease
treatment[6, 7].
However, the mechanism for violations micro-
biome with antibiotics, depending on the dose and the
duration of use of broad-spectrum antibiotics is not
knousn, and alsothe guidelines on use of probiotics
after antibacterial agents depending on their dosesis
not developed [8, 9]. Experimental studies are aimed
to establish violations species composition and
population levels of microbiome under the influence
of different doses of broad-spectrum antibiotics,
duration of use, taking into account function of the
immune system and the methods of application for
pre-and probiotics tocorrect qualitative and
quantitative composition of the microbiome habitat
[10].
Materials and methods
The experimental study was conducted on 70
white inbredalbino rats weighing 180 - 220 g. The
animals were obtained from the vivarium of
Bukovina state medical university, they were kept
under standard conditions on a standard diet and
taken in experiment after a 2 - week quarantine in
the absence of any signs of disease. Experiments
were conducted in accordance with the Law of
Ukraine ¹ 3447-IV and the European Convention
for the Protection of Vertebrate Animals used for
research and other purposes.
Effect of different doses of tetracycline on the
microbiota of the large and distal small intestine was
studied by daily oral administration with metallic pro-
be directly into the ratsstomach within 5 days in a
volume less than 1 ml tetracycline at avera-
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getherapeutic dose (20 mg / kg) and maximum (50
mg / kg). Control animals within 5 - days were
injected daily vith1 ml isotonic sodium chloride
solution into the stomach.
The process of self-healing vas performed by
accepted in standard vivarium conditions for 10 days
after administration of different doses of tetracycline.
Species composition and population-level micro-
biome different habitats studied microbiological and
mycological method I.Y.Sydorchuk, O.I.Holyar (2009
- 2010), [12 - 15].
Results and Discussion
The first stage of research was to study the spe-
cies composition and population levels and the
microbiota of  biological layer in mucus membrsne of
the distal part of  small intestine and the large intes-
tine.
The effect of different therapeutic doses of
tetracycline hydrochloride (medium - 20 mg / kg and
maximum - 50 mg / kg) on the species composition
(qualitative) and the population (quantitative) level of
indigenous obligate anaerobic bacteria of the genus
Bifidobacterium, Lactobacillus, Peptostreptococcus,
Eubacterium, Bacteroides and facultative anaerobic
bacteria of the genus Enterococcus, and the
qualitative and quantitative composition of facultative
anaerobic and aerobic Enterobacteriaceae (bacteria
of the genus Escherichia, Proteus, Klebsiella,
Edwardsiella, Pantotea, Staphylococcus, etc.)
Hidrîhloryde tetracycline in dose of 20 mg / kg
(therapeutic dose) administered for 5 days directly
into the stomach of intact white rats leads to minor
changes in species composition and population levels
but deep violations of oral microbiota of the colon by
reducing the quantitative composition of autoch-
thonous obligate anaerobic bifidobacteria, lactobacilli,
eubacteria (p <0.001) and significant (p <0.001 -
<0.05) increase in population-level electives Bacte-
roides, peptokokki, clostridia, enterobacteria
(edvardsiyel, pantotey, Klebsiella, Proteus).
That  dose of tetracycline hydrochloride weakens
the colonization resistance of the mucous membrane
of the colon due to profound changes in species
composition of the microbiota biological layer on
mucus membrane of habitat. That leads to the
elimination of bifidobacteria, eubacteria, enterococci,
peptostreptokokki and colonization of the colon
mucosa conditionally pathogenic enterobacteria
(edvardsiyelamy, Klebsiella, pantoteyamy, Proteus),
staphylococci, peptokokki, clostridium and pseudo-
monas.
Average dose of tetracycline hydrochloride in
intact animals after 5 days of administration leads to
a significant (p <0.01) reduction in the number of
lactobacilli and increase population levels of Entero-
bacteriaceae and Bacteroides and E. coli.
Of particular importance in the formation of
infection in the distal small intestine, which is
characterized by significant vascularization and
localization of lymphoid clusters associated with
mucous membrane, the surface of which, is the most
capable for resorption of antigens (microorganisms)
comparatively other parts of the intestine. This gives
it a propensity to contact with microorganisms, anti-
biotics and various chemicals. The treatment of
acute infectious intestinal diseases using causal
antibiotics, effects the intestines endogenousmik-
robiotato  overgrowth(dysbiosis).
Colonization resistance of the mucosa of the dis-
tal small intestine under the influence of medium
doses of tetracycline is undergoing profound changes,
characterized by changes in qualitative and quanti-
tative interrelations, thus reveals a pronounced deficit
of obligate indigenous bifidobacteria, lactobacilli,
enterococci, and peptostreptokokkipryepitelanoyi
biofilm contamination of the mucous membrane of
pathogenic and conditionally pathogenic enterobac-
teria , staphylococcus, clostridium and peptokokki
that reach this biotope high population level,
quantitative dominance coefficient and significance.
Thus, average therapeutic dose of tetracycline
hydrochloride (20 mg / kg) per oral administration in
intact white rats for 5 days leading to the elimination
of the distal small intestine cavity enterococci, hay
bacillus, peptostreptokokki, in some animals -
bifidobacteria and lactobacilli. Under the impact of
this dose it comes a powerful oral contamination of
the distal small bowel pathogens (Escherichia entero-
toksyhennymy) and opportunistic (Proteus, Klebsiella,
pantoteyamy, edvardsiyelamy) enterobacteria,
staphylococci and bacteria of the genus Clostridium.
As a result, in the cavity of the small intestine it
creates a pronounced shortage of indigenous obligate
anaerobic bifidobacteria, lactobacilli, eubacteria and
enterococci, peptostreptokokki. Against this back-
ground, disrobed increases the level of pathogenic
and conditionally pathogenic enterobacteria, staphy-
lococci and clostridia.
Using a medium therapeutic doses of tetracycline
hydrochloride does not affect the quality and quantity
of Bacteroides, eubacteria, but a growing number of
E. coli.
Despite the frequent use of tetracycline at
present, the effect of these drugs on the normal
intestinal flora has not been studied. In previous
studies we examined the influence of the features on
abdominal mukoznu microbiota and the colon and the
distal small intestine average therapeuticdose (20 mg
/ kg) of tetracycline hydrochloride. It isnecessoryto
studiyd side effects of antibiotic use at the maximum
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therapeutic dose - 50 mg / kg.
The maximum therapeutic dose (50.0 mg / kg) of
tetracycline hydrochloride introduced directly into the
stomach for 5 days leads to a pronounced imbalance
of microflorapreepithelial biofilm of mucos mem-
brane of the colon, characterized by sterilizing effect
of antibiotic concerning endogenous obligate anae-
robic, facultative anaerobic and aerobic bacteria. In
preepithelial biofilm of membrane mucosa of the
colon bacteroides are only in small amounts and
conditionally pathogenic enterobacteria (Klebsiella,
pantoteyi) peptokokki and clostridia, which conta-
minatemucos membrane of the colon and reach the
minimum population level.
Thus, the maximum therapeutic dose (50.0 mg /
kg) of tetracycline hydrochloride, applid directly into
the stomach white rats for 5 days, caused the elimi-
nation of oral colon autochthonous obligate anaerobic
bacteria of the genus Bifidobacterium, Lactobacillus,
Peptostreptococcus and facultative anaerobic and
aerobic - Enterococcus, B. subtilis (transient microor-
ganisms) and contamination by pathogenic oral colon
(enterotoksyhennymy Escherichia) and opportunistic
pathogens (Klebsiella) enterobacteria, peptokokki and
clostridium. Last microorganisms reach high
population levels. This dose results in a sterilizing ef-
fect on the content of oral colon of experimental
animals.
The main source of oral microflora in the distal
small intestine is mucous microflora (microbiota
pryepitelialnoyi biological film mucosa) and to a
lesser extent allochthonousmicroflora that falls into
this habitat with food and drinks. Microflo-
rapreepithelial biological film is the most stable and
plays a significant role in colonization resistance and
maintaining the health of the host. Therefore, the
next step on the impact of the maximum therapeutic
dose (50.0 mg / kg) of tetracycline on the microbiota
of the distal small intestine microflorapreepithelial
was to study the biological film of this habitat.
The process of self-healing within 10 days of the
oral microbiota in the colon in experimental animals
that received within 5 days maximum therapeutic
dose of tetracycline hydrochloride(50 mg / kg), is
characterized by the appearance of moderate
population level in all animals indigenous obligate
anaerobic bacteria of the genus Lactobacillus, Bifido-
bacterium, Bacteroides, Peptostreptococcus and
facultative anaerobic and aerobic bacteria of the
genus Escherichia, Enterococcus, Bacillus, decrease
opportunistic enterobacteria sowing and emergence
of yeasts of the genus Candida and other opportu-
nistic microorganisms.
After the cessation of oral administration of tet-
racycline in doses of 50 mg / kg in the self-healing
within 10 days of emerging tend of normalization of
oral microflora in the distal small intestine due to the
appearance and achieving moderation in oral ulcers
obligate indigenous bacteria of the genus Bifido-
bacterium, Lactobacillus, Peptostreptococcus,
Enterococcus and elimination of oral ulcers some
genera of Enterobacteriaceae (Klebsiella).
Preepithelial biofilm microbiota on mucosa of the
distal small intestine tends to normalize due to the
elimination of this habitat specific Enterobacteriaceae
(Pantotea) and the emergence of indigenous obligate
anaerobic bacteria of the genus Bifidobacterium,
Lactobacillus, Eubacterium, Peptostreptococcus,
facultative anaerobic and aerobic bacteria of the
genus Enterococcus, Escherichia, that achieve
moderate population level and become dominant,
forming the main habitat microbiota.
After creating a model of intestinal dysbiosis
administration orally daily for 10 days of tetracycline
in maximum therapeutic dose on the sixth day spent
decontamination measures aimed to correcting
qualitative and quantitative composition of the
microbiota of oral and preepithelial biological film
mucosa of colon and distal small intestine, with
"Bififormu children powder 21. "
Thus, oral use in animals ofBififormuat dysbiosis
of III - IV degree for 10 days significantly improves
the qualitative and quantitative composition of the
microbiota of oral colon due to the appearance and
achieving moderate (normal) population-level quan-
titative dominance coefficient and coefficient signi-
ficance bacteria of the genusBifidobacterium,
Lactobacillus, Bacteroides, Peptostreptococcus, En-
terococcus, Escherichia.
Above listed proved that the use ofBififormu wi-
thin 10 days actively improves the qualitative and
quantitative composition of microflora content cavity
distal small intestine. However, full recovery during
this period does not occur, requiring continuation of
probiotics administration.
Conclusions
1. The average therapeutic dose of tetracycline
hydrochloride(20 mg / kg), introduced directly into
the stomach by metallic probe leads to minor changes
in species composition and population levels deep
violate ed of oral microbiota and biological preepitelial
film mucosa of the colon and distal small intestine -
reducing the quantitative composition of indigenous
obligate anaerobic bacteria of the genus Bifidobac-
terium, Lactobacillus, Eubacterium (p <0,001) and
significant (p <0,001 - <0,05) increase in population
levels of opportunistic bacteria of the genus
Bacteroides, Peptococcus, Clostridium and Entero-
bacteriaceae (bacteria of the genus Klebsiella,
Edwardsiella, Pantotea, Proteus ). The indicated dose
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process of the natural self-healing occurs more
actively and intensively, which makes it possible to
recommend the use of broad-spectrum antibiotics in
maximum therapeutic doses for 5 days.
6 "Bifiform baby powder number 21" is an effec-
tive means of restoring the qualitative and quantitative
composition of microflora and oral preepithelial
biological film mucosa of the colon and distal small
intestine of white rats in which intestinal dysbiosiswas
formed by a five-day administration of tetracycline in
the maximum therapeutic dose (50 mg / kg).
Usage of Bifiform leads to decontamination and
elimination of pathogens (Escherichia enterotoksy-
hennyh) and opportunistic enterobacteria, peptococci,
clostridia, staphylococci and other microorganisms.
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ÑÒÅÏÅÍÜ ÂËÈßÍÈß ÒÅÒÐÀÖÈÊËÈÍÀ ÍÀ
ÌÈÊÐÎÁÈÎÖÅÍÎÇ ÊÈØÅ×ÍÈÊÀ È ÅÃÎ
ÊÎÐÐÅÊÖÈß ÏÐÅÏÀÐÀÒÎÌ "ÁÈÔÈÔÎÐÌ-21"
È.È. Ñèäîð÷óê, Î.È.Ãîëÿð, Ì.Î.Ñîêîëåíêî
Ðåçþìå. Â ðàáîòå ïðèâåäåíî òåîðåòè÷åñêîå îáîáùåíèå è
íàó÷íîå ðåøåíèå íàó÷íîé çàäà÷è, êîòîðàÿ ïðîÿâëÿåòñÿ â
ýêñïåðèìåíòàëüíîì îáîñíîâàíèè ïîáî÷íîãî äåéñòâèÿ
of antibiotics leads to the weakening of colonization
resistance of the mucous membrane of the colon due
to the profound changes of the quality of the mic-
robiota preepithelial biological film that manifests
elimination of biofilm preepithlialmucosa of the colon
by representatives of indigenous obligate anaerobic
microflora.
2. Maximum therapeutic dose of tetracycline (50
mg / kg) daily orally for 5 days shows a sterilizing
effect on the content and in the biofilm pryepitelialniy
mucosa of the colon and distal small intestine, contri-
buting significantly reduced colonization resistance of
the colon mucosa and distal small intestine and it can
become a gateway to the penetration of pathogenic
and conditionally pathogenic enterobacteria and
others. through the wall of the colon into the blood
and internal organs.
3. When using the average therapeutic doseof
tetracycline (20 mg / kg) after 10 days oral micro-
biota and mucosa of the colon and distal small
intestine is characterized by gradual slow (at 3.33 -
35.1%) growth of obligate indigenous bacteria of the
genus Bifidobacterium, Lactobacillus, Eubacterium,
but their population level remains unchanged. The
state of mucosamicroflora (preepithelial biofilm) is
characterized by increasing population levels, cons-
tancy index and quantitative dominance factor in
bacteria Lactobacillus, Bacteroides, Peptococcus,
Clostridium, Staphylococcus and opportunistic
enterobacteria. This preepithelialbiofilm mucosa of
the colon and distal small intestinearecontaminated
with yeast fungi of Candida.
4. The process of self-healing within 10 days of
the oral microbiota of the colon and distal small
intestine of white rats for 5 days receive maximum
therapeutic dose (50 mg / kg), tetracycline, characte-
rized by the appearance of moderate population level
in all animals indigenous obligate bacterial genus
Bifidobacterium, Lactobacillus, Bacteroides, Pep-
tostreptococcus, Enterococcus, Escherichia; decline
in a sowing of opportunistic enterobacteria and yeast-
like fungi contamination habitat genus Candida, other
opportunistic microorganisms. The broken qualitative
and quantitative composition of the microbiota
preepithelial biofilm mucosa of the colon and distal
small bowel restored by colonization of mucosal
endogenous obligate autochthonous bacteria of the
genus Bifidobacterium, Lactobacillus, Bacteroides,
etc.
5. Comparative analysis of the natural self-healing
oral microbiota and preepithelial biofilm intestinal
mucosa (colon and distal small intestine) after using
the average and maximum doses of broad-spectrum
antibiotics, confirming that after using the maximum
therapeutic dose that causes a sterilizing effect, the
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àíòèáèîòèêà øèðîêîãî ñïåêòðà äåéñòâèÿ (òåòðàöèêëèíà
ãèäðîõëîðèäà) íà êà÷åñòâåííûé è êîëè÷åñòâåííûé ñîñòàâ
ìèêðîáèîòû ïîëîñòè è ïðèýïèòåëèàëüíîé áèîëîãè÷åñêîé
ïëåíêè ñëèçèñòîé îáîëî÷êè òîëñòîé è äèñòàëüíîãî îòäåëà
òîíêîé êèøêè; îáîñíîâàíèè ïðîöåññîâ ñàìîâîññòàíîâëåíèÿ â
òå÷åíèå 10 äíåé êà÷åñòâåííîãî è êîëè÷åñòâåííîãî ñîñòàâà
ìèêðîáèîòû ýòîãî áèîòîïà â çàâèñèìîñòè îò äîçû (ñðåäíåé è
ìàêñèìàëüíîé òåðàïåâòè÷åñêîé äîçû) ïðè ïåðîðàëüíîì
ââåäåíèè áåëûì êðûñàì, à òàêæå âëèÿíèå ïðîáèîòèêà
"Áèôèôîðì äåòñêèé ïîðîøîê ¹ 21" íà âîññòàíîâëåíèå
íàðóøåííîãî êà÷åñòâåííîãî è êîëè÷åñòâåííîãî ñîñòàâà
ìèêðîáèîìû êèøå÷íèêà.
Êëþ÷åâûå ñëîâà: ìèêðîáèîìà, òîëñòàÿ è òîíêàÿ êèøêà,
íîðìîôëîðà, äèñáàêòåðèîç, òåòðàöèêëèí.
ÑÒÓÏ²ÍÜ ÂÏËÈÂÓ ÒÅÒÐÀÖÈÊË²ÍÓ ÍÀ
Ì²ÊÐÎÁ²ÎÖÅÍÎÇ ÊÈØÅ×ÍÈÊÓ ÒÀ ÉÎÃÎ
ÊÎÐÅÊÖ²ß ÏÐÅÏÀÐÀÒÎÌ "Á²Ô²ÔÎÐÌ-21"
².É. Ñèäîð÷óê, Î.².Ãîëÿð, Ì.Î.Ñîêîëåíêî
Ðåçþìå. Ó ðîáîò³ íàâåäåíå òåîðåòè÷íå óçàãàëüíåííÿ ³
íàóêîâå âèð³øåííÿ íàóêîâî¿ çàäà÷³, ùî âèÿâëÿºòüñÿ â
åêñïåðèìåíòàëüíîìó îáãðóíòóâàíí³ ïîá³÷íî¿ ä³¿ àíòèá³îòèêó
øèðîêîãî ñïåêòðó ä³¿ (òåòðàöèêë³íó ã³äðîõëîðèäó) íà
ÿê³ñíèé òà ê³ëüê³ñíèé ñêëàä ì³êðîá³îòè ïîðîæíèíè ³
ïðèåï³òåë³àëüíî¿ á³îëîã³÷íî¿ ïë³âêè ñëèçîâî¿ îáîëîíêè
òîâñòî¿ òà äèñòàëüíîãî â³ää³ëó òîíêî¿ êèøêè; îá´ðóíòóâàíí³
ïðîöåñ³â ñàìîâ³äíîâëåííÿ ïðîòÿãîì 10 äí³â ÿê³ñíîãî ³
ê³ëüê³ñíîãî ñêëàäó ì³êðîá³îòè öüîãî á³îòîïó ó çàëåæíîñò³
â³ä äîçè (ñåðåäíüî¿ ³ ìàêñèìàëüíî¿ òåðàïåâòè÷íî¿ äîçè) ïðè
ïåðîðàëüíîìó ââåäåí³ á³ëèì ùóðàì, à òàêîæ âïëèâ
ïðîá³îòèêà "Á³ô³ôîðì äèòÿ÷èé ïîðîøîê ¹ 21" íà
â³äíîâëåííÿ ïîðóøåíîãî ÿê³ñíîãî ³ ê³ëüê³ñíîãî ñêëàäó
ì³êðîá³îìè êèøå÷íèêó.
Êëþ÷îâ³ ñëîâà: ì³êðîá³îìà, òîâñòà ³ òîíêà êèøêà,
íîðìîôëîðà, äèñáàêòåð³îç, òåòðàöèêë³í.
Áóêîâèñíüêèé äåðæàâíèé ìåäè÷íèé óí³âåðñèòåò
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